Baloxavir-D4 | CAS 2415027-80-2 - Request Quote
Baloxavir-D4
| SZ CAT No: | SZ-B052D01 |
| CAS No | 2415027-80-2 |
| Mol.F. | C24H15D4F2N3O4S |
| Mol.Wt. | 487.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Baloxavir-D4 is chemically (R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione-3,3,4,4-d4. Baloxavir-D4 is supplied with detailed characterization data compliant with regulatory guideline. Baloxavir-D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baloxavir marboxil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2415027-80-2
Purchase 2415027-80-2
Order 2415027-80-2
Enquire 2415027-80-2
price of 2415027-80-2
2415027-80-2 Supplier
2415027-80-2 Manufacturer
2415027-80-2 Exporter
buy high quality Baloxavir-D4
Purchase Baloxavir-D4
Baloxavir-D4 suppliers
Baloxavir-D4 manufacturers
Baloxavir-D4 price
Order Baloxavir-D4
Enquire Baloxavir-D4
Baloxavir-D4 cost
Baloxavir-D4 Supplier
Baloxavir-D4 Distributor
Baloxavir-D4 for Method Validation
Baloxavir marboxil Reference Standard
Baloxavir-D4 for ANDA Filing
Baloxavir-D4 for Forced Degradation Studies
Baloxavir-D4 Identification Standards
Baloxavir-D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


